Loading...
Loading...
Among the 3 tracked institutional investors we monitor, APRE (APREA THERAPEUTICS INC) is held with a combined value of $75.18K across 91,690 shares. The largest holder is VANGUARD GROUP INC with a position worth $49.55K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter.
Total Institutional Value
$75.18K
Total Shares Held
91,690
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $49.55K | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $19.15K | 0.00% | New |
| 3 | BlackRock, Inc. | $6.49K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of APRE with a position worth $49.55K, representing 0.00% of their portfolio. In total, 3 institutional investors hold APRE with a combined value of $75.18K.
In the most recent quarter, 2 funds opened a new position in APRE.
Institutional investors hold $75.18K worth of APRE stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $49.55K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For APRE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their APRE positions.